![]() ALX Oncology ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment. | ![]() Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. | ||
Founding Date | Founding Date 2005 | Founding Date 2015 | Founding Date 1998 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Houston, US HQ San Diego, US | Locations Burlingame, US HQ Dublin 2, IE | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more |
Employees | Employees 3 | Employees 743% increase | Employees 3,25622% increase |
Financial | |||
Net income | Net income N/A | Net income ($101.7m) (FY, 2025) | Net income ($610.3m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 54.2m | Total funding raised $ 166m | Total funding raised $ 164m |

ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.
View company
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View company